Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway
Bingtian Xu, Tiantian Wang, Jiao Xiao, et al.
Biochemical Pharmacology (2019) Vol. 163, pp. 234-249
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway
Bingtian Xu, Yunyun Qin, Dan Li, et al.
Redox Biology (2019) Vol. 28, pp. 101342-101342
Open Access | Times Cited: 101
Hispidulin exhibits neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis
Pengpeng An, Jing Xie, Sha Qiu, et al.
Life Sciences (2019) Vol. 232, pp. 116599-116599
Closed Access | Times Cited: 99
DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia‐Reperfusion by Regulating Glycolysis through PDK2‐PDH‐Nrf2 Axis
Xiaoyong Zhao, Shan Li, Yunchang Mo, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 62
The mechanism of ferroptosis regulating oxidative stress in ischemic stroke and the regulation mechanism of natural pharmacological active components
Kailin Yang, Liuting Zeng, Xiao Yuan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113611-113611
Open Access | Times Cited: 55
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway
Bingtian Xu, Jiangping Xu, Ningbo Cai, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 281-296
Closed Access | Times Cited: 65
Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
Zhongqi Bu, Haiyang Yu, Jue Wang, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110375-175909142110375
Open Access | Times Cited: 46
Unravelling neuroregenerative and neuroprotective roles of Wnt/β-catenin pathway in ischemic stroke: Insights into molecular mechanisms
Srikanth Yadava, Dontiboina Harikrishna Reddy, Venkata Prasuja Nakka, et al.
Neuroscience (2024)
Closed Access | Times Cited: 6
CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway
Jiahui Gao, Lin-Hao He, Xiao-Hua Yu, et al.
Journal of Lipid Research (2019) Vol. 60, Iss. 12, pp. 2020-2033
Open Access | Times Cited: 48
Roflupram exerts neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson's disease
Jiahong Zhong, Wenli Dong, Yunyun Qin, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2333-2350
Open Access | Times Cited: 47
Ferrostatin-1 alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β signaling pathway
Xinyao Liu, Yue Du, Jian Liu, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 146-157
Open Access | Times Cited: 24
PDE4D: A Multipurpose Pharmacological Target
Matteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8052-8052
Open Access | Times Cited: 5
Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
Laura Ponsaerts, Lotte Alders, Melissa Schepers, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 703-703
Open Access | Times Cited: 30
Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats
Bingtian Xu, Mengfan Li, Ke-chun Chen, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 3, pp. 499-512
Open Access | Times Cited: 22
Discovery of Novel 3-Amino-4-alkoxyphenylketones as PDE4 Inhibitors with Improved Oral Bioavailability and Safety against Spatial Memory Impairments
Chuang Xia, Jiapeng He, Kai-Wen Feng, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 3, pp. 390-405
Closed Access | Times Cited: 19
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2713-2741
Closed Access | Times Cited: 12
PDE4 Inhibitors for Disease Therapy: Advances and Future Perspective
Baochan Du, Min Luo, Changyu Ren, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 13, pp. 1185-1207
Closed Access | Times Cited: 11
Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
Pooja Devi Nongthombam, Reena Haobam
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
Min Kyu Park, Hyun Wook Yang, Seo Young Woo, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 86-86
Open Access
A novel PDE4 inhibitor ZX21011 alleviates neuronal apoptosis by decreasing GSK3β-mediated Drp1 Ser616 phosphorylation in cerebral ischemia reperfusion
Huizhen Wen, Xingxing Tu, Fulan Luo, et al.
Chemico-Biological Interactions (2025), pp. 111405-111405
Closed Access
XQ-1H promotes cerebral angiogenesis via activating PI3K/Akt/GSK3β/β-catenin/VEGF signal in mice exposed to cerebral ischemic injury
Yuxiang Fei, Bo Zhao, Jianping Zhu, et al.
Life Sciences (2021) Vol. 272, pp. 119234-119234
Closed Access | Times Cited: 24
Neuroprotective effects of oxymatrine on hypoxic–ischemic brain damage in neonatal rats by activating the Wnt/β-catenin pathway
Xiaobing Lan, Yuan-Shu Ni, Ning Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114266-114266
Open Access | Times Cited: 9
Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification
Rui Li, Qi Lou, Tingting Ji, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118157-118157
Closed Access | Times Cited: 3
Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/Reperfusion
Kechun Chen, Bingtian Xu, Lu Long, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Inhibition of PDE4 Attenuates TNF-α-Triggered Cell Death Through Suppressing NF-κB and JNK Activation in HT-22 Neuronal Cells
Jiao Xiao, Rumeng Yao, Bingtian Xu, et al.
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 3, pp. 421-435
Closed Access | Times Cited: 23
Long Non-coding RNAMALAT1 Knockdown Alleviates Cerebral Ischemia/Reperfusion Injury of Rats Through Regulating the miR-375/PDE4D Axis
Guangjian Zhang, Qingdong Wang, Daoqing Su, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top